Gimv — Full Portfolio

Itineris develops utility software solutions that help water and energy companies optimize operations, manage energy and water consumption, and support environmental goals.

AI & Machine LearningEnergyEnterprise SoftwareGovTechSaaSNot stated

EVEdgard Vermeersch(CEO & Founder)in

Co-investorsSMSmartFinALAlychloPMPMV

Paleo develops plant-based protein products designed to replicate the taste and qualities of animal meat, addressing sustainability in food production.

AgTechBiotechCircular EconomyClimate TechFoodTechImpact & Social Good

HSHermes Sanctorum(Co-founder & CEO)inAndy de Jong(Co-founder & Board Director)in

BoardLieven De Smedt(Chairman of the Board)

Co-investorsSISiddhi CapitalPLPlanet A Ventures

Topas Therapeutics develops nanoparticle-based therapies to induce immune tolerance for autoimmune and immune-mediated diseases.

BiotechHealthtech

HFHugo Fry(Chief Executive Officer)inChristian Schröter(Chief Operating Officer)Cristina de Min(Chief Medical Officer)Anne Burger(Chief Financial Officer)AMAlex Marshall(Chief Business Officer)in

Co-investorsEMEMBL VenturesBOBoehringer Ingelheim Venture FundBIBioMedPartnersEPEpidarex Capital

BioConnection is a Contract Development and Manufacturing Organization (CDMO) specializing in filling, finishing, and lyophilizing injectable biopharmaceutical products.

Advanced ManufacturingBiotechHealthtechMedical DevicesOss, NL

Co-investorsBOBOM

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

RHRafiq Hasan(CEO and Managing Director)inMAMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsCACambridge Innovation CapitalHAHadean VenturesSESeroba Life SciencesBGBGVBIBioGeneration VenturesFOForbion+1 more

Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions.

AI & Machine LearningBiotechDeep TechMedical Devices

Co-investorsPMPMVANAndera PartnersVEVesalius Biocapital PartnersOMOmnes Capital

FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.

Digital HealthHardwareMedical DevicesDublin, IE

Co-investorsANAndera PartnersLILightstone VenturesLOLongitude CapitalNENew Enterprise Associates (NEA)GIGilde HealthcareIRIreland Strategic Investment Fund+5 more

Hansea is a Belgian mobility company that provides customized passenger transport and integrated mobility solutions, including bus and coach rentals, through a network of more than 45 locations across Belgium.

Mobility & Transportation

Co-investorsCUCube Infrastructure Managers

ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.

BiotechHealthtech

Co-investorsAGAgent CapitalANAndera PartnersKUKurma PartnersPFPfizer Venture InvestmentsPUPureos BioventuresALAlexandria+4 more

JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.

Digital HealthHealthtechMedical DevicesIrvine, US

HFHans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)

BoardAKArnd Kaltofen(Director)inErik Amble(Director)

Co-investorsANAndera PartnersBABain Capital Life SciencesVIVI PartnersATAtlas VentureINInnovatus Capital PartnersLELegend Capital

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

RHRoger Heerman(Chief Business/Operating Officer / Co-Founder)inFMFrazer Morgan(Chief Development Officer / Co-Founder)inRCRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJBJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5A5AM VenturesATAtlas VentureRARA CapitalEQEQT Life SciencesSISixty Degree CapitalVIVivo Capital+1 more

SBS (Smart Battery Solutions) is a German manufacturer that develops, produces, and services lithium-ion batteries, covering the full product life cycle for various industries and applications such as warehouse robotics, industrial drones, rehab technology, light mobility, e-scooters, e-watercraft, e-bikes, and e-cargo.

EnergyHardwareMobility & Transportation

Spineart designs and manufactures spinal prosthetics and surgical instruments for orthopedic procedures, with a focus on cervical disc prostheses and fusion solutions for surgeons and hospitals.

Deep TechHardwareMedical DevicesGeneva, CH

Jerome Trividicin

SynOx Therapeutics develops emactuzumab, a monoclonal antibody treatment for tenosynovial giant cell tumours (TGCT) and macrophage-mediated diseases.

BiotechHealthtechMedical Devices

RBRay Barlow(Chief Executive Officer)in

Co-investorsHEHealthCapBIBioqube VenturesFOForbionMEMedicxi